← Consumer Healthcare Products Association
FDANonrulemakingFDA-2023-D-5470

Real-World Evidence: Considerations Regarding Non-Interventional Studies for Drug and Biological Products; Draft Guidance for Industry; Availability

RIN
—
Last modified
Oct 4, 2024
Comment window
closed 770d ago
Consumer Healthcare Products Association filings
1

Activity

Consumer Healthcare Products Association filed 1 comment on this docket between Jun 17, 2024 and Jun 17, 2024. 0 other organizations filed here. The comment window closed 770d ago.

What Consumer Healthcare Products Association filed (1)

Jun 17, 2024· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2023-D-5470-0011

Comments from the Consumer Healthcare Products Association (CHPA) on FDA's draft guidance on Real-World Evidence (RWE) Consierations Regarding Noninterventional Studies for Drug and Biological Products (March 2024)

View on regulations.gov →

Abstract

OPEN

View on regulations.gov →

Co-filers (0)

See everyone who commented →